<DOC>
	<DOC>NCT01380548</DOC>
	<brief_summary>This study is designed to evaluate efficacy and dose-dependency of 5-aminolevulinic acid in subjects with iron deficiency anemia.</brief_summary>
	<brief_title>Effects of 5-Aminolevulinic Acid on Iron Deficiency Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia, Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>Premenopausal women with hemoglobin ≥ 9.0 g/dl and ≤ 12.0 g/dl Willing not to donate blood during the study Informed consent signed History of porphyria, hemochromatosis, or viral hepatitis Anemia other than iron deficiency BMI ≤ 18 kg/m2 or ≥ 30 kg/m2 Pregnant or nursing a child Participation in any clinical trial within 90 days of the commencement of the trial Renal or hepatic dysfunction Heart disease Subjects who are taking medicines or functional food that may affect hemoglobin level</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>